Monday, February 22, 2016

Cox Branson offering new heart failure monitoring solution

A new wireless heart failure monitoring system, available at Cox Branson, sends pressure readings directly to a patient's doctor and can help providers intervene quickly before a patient's heart problem worsens.

There’s a new way to manage heart failure, and CoxHealth is the only hospital system in southwest Missouri where it can be found.

The procedure consists of a sensor being implanted in a patient’s pulmonary artery. Once implanted, the wireless sensor sends pressure readings directly to the patient’s doctor – which means that when there’s a heart-related issue, the doctor knows right away and can help intervene before the problem gets worse. The procedure, which debuted at Cox South last fall, is expected to be performed for the first time at Cox Branson this spring.

“This new technology gives us the opportunity to give patients a better quality of life,” says Narin Arunakul, MD, a cardiologist with Cox Branson. “The sooner we address issues, the greater ability we have to intervene and manage a patient’s condition before it deteriorates. This extra time can truly be life-changing for our patients.”

“What makes this device so incredible is the fact that it will allow us to catch a problem before symptoms occur and ultimately, we will be able to prevent further heart damage,” said Ryan Sigle, RN, assistant nurse manager, Cox Branson Cardiac Cath Lab. 

The system’s sensor, part of the CardioMEMS Heart Failure System, is implanted during a non-surgical procedure and directly measures pressure on the artery. It’s the only FDA-approved heart failure monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage heart failure.

The sensor is designed to last the patient’s lifetime and doesn’t require batteries. There is no pain or sensation for the patient during the readings. And its results are in the data: A clinical trial showed that the CardioMEMS technology reduces heart failure hospital admissions by up to 37 percent.